In the first quarter of 2024, with the continuous introduction of favorable policies, the listing of Chinese concept stocks in the United States showed a trend of recovery and recovery.

The media technology company under former US President Trump was able to go public at lightning speed through SPAC, making Trump one of Bloomberg's top 400 global billionaires.

On January 24, 2024, the US Securities and Exchange Commission (SEC) passed the SPAC regulatory regulations with a 3:2 vote. The new SPAC regulations will further promote the development and regulation of SPAC listings.

More and more small and medium-sized enterprises are choosing a "two-step approach", which not only attracts overseas investors but also lays a solid foundation for sprinting into the US main board market.

The new regulations on filing promote standardized development through institutional mechanisms, better play the role of the rule of law in stabilizing expectations and benefiting the long-term, and promote the formation of a good market ecology. The China Securities Regulatory Commission and relevant regulatory authorities will respect the independent choices of legally compliant enterprises and provide support.

Louts raises $880 million through SPAC

The 33-year-old Chinese entrepreneur successfully led the start-up CG Oncology to achieve an initial public offering, resulting in a market valuation of nearly 3 billion US dollars specifically for bladder cancer treatment.

The conversion of Kangbaier to NASDAQ is driven by the prevailing trend and the desire to capitalize on it, as well as the potential for success within this trend.